Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1515-1518

  Van Heirstraeten, Liesbet ^a   Coenen, Samuel ^a   Lammens, Christine ^a   Hens, Niel ^b   Goossens, Herman ^a   Malhotra Kumar, Surbhi ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; PENICILLIN G; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BELGIUM; DISK DIFFUSION; DRUG USE; HUMAN; MACROLIDE RESISTANT STREPTOCOCCUS PYOGENES; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS PYOGENES;

EID: 84865336679     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.120049     Document Type: Article

References (15)

1. Malhotra-Kumar S, Mazzariol A, Van Heirstraeten L, Lammens C, de Rijk P, Cornaglia G, et al. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A). J Antimicrob Chemother. 2009;63:42-46. doi:10.1093/jac/dkn432
2. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482-492. doi:10.1086/324626
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587.
4. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369:482-490. doi:10.1016/S0140-6736(07)60235-9
5. Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 2010;8:260-271.
6. Malhotra-Kumar S, Lammens C, Chapelle S, Wijdooghe M, Piessens J, Van Herck K, et al. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003. Emerg Infect Dis. 2005;11:939-942. doi:10.3201/eid1106.041247
7. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011;66(Suppl 6):vi3-vi12. doi:10.1093/jac/dkr453
8. Goossens H, Coenen S, Costers M, De Corte S, De Sutter A, Gordts B, et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill. 2008;13:pii: 19036.
9. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441-446. doi:10.1056/NEJM199708143370701
10. Cizman M, Beovic B, Seme K, Paragi M, Strumbelj I, Muller-Premru M, et al. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use. Int J Antimicrob Agents. 2006;28:537-542. doi:10.1016/j.ijantimicag.2006.07.023
11. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L, et al. The population genetics of antibiotic resistance. Clin Infect Dis. 1997;24(Suppl 1):S9-S16. doi:10.1093/clinids/24.Supplement_1.S9
12. Rozen DE, McGee L, Levin BR, Klugman KP. Fitness costs of fl uoroquinolone resistance in Streptococcus pneumonia. Antimicrob Agents Chemother. 2007;51:412-416. doi:10.1128/AAC.01161-06
13. Gillespie SH, ed. Antibiotic resistance: methods and protocols (Methods in Molecular Medicine). Totowa (NJ): Humana Press; 2001.
14. Foucault ML, Depardieu F, Courvalin P, Grillot-Courvalin C. Inducible expression eliminates the fi tness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A. 2010;107:16964-16969. doi:10.1073/pnas.1006855107
15. Littauer P, Caugant DA, Sangvik M, Hoiby EA, Sundsfjord A, Simonsen GS. Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob Agents Chemother. 2006;50:1896-1899. doi:10.1128/AAC.50.5.1896-1899.2006